Although RUFY4 is reported to be the first molecule that affects autophagy and endosome dynamics in a subset of immune cells and that RUFY4 is an important factor that defines the nature of the response of cells to the direct immune environment [12], there is no strong evidence that RUFY4 is relevant to any type of cancer. Here, RUFY4 is linked to cancer.